Related references
Note: Only part of the references are listed.Perioperative management for pancreatoduodenectomy following severe acute pancreatitis in patients with periampullary cancer: our experience with six consecutive cases
Sadaki Asari et al.
SURGERY TODAY (2015)
Prognostic value of systemic inflammation-based markers in advanced pancreatic cancer
H. L. Martin et al.
INTERNAL MEDICINE JOURNAL (2014)
Pancreaticodigestive anastomosis and the postoperative management strategies to prevent postoperative pancreatic fistula formation after pancreaticoduodenectomy
Daisuke Hashimoto et al.
SURGERY TODAY (2014)
Preoperative Gemcitabine-Based Chemoradiation Therapy for Resectable and Borderline Resectable Pancreatic Cancer
Hidenori Takahashi et al.
ANNALS OF SURGERY (2013)
Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer
M. Stotz et al.
BRITISH JOURNAL OF CANCER (2013)
Elevated pre-operative neutrophil to lymphocyte ratio predicts disease free survival following pancreatic resection for periampullary carcinomas
Mazin O. Hamed et al.
PANCREATOLOGY (2013)
Early Mortality Risk Score: Identification of Poor Outcomes Following Upfront Surgery for Resectable Pancreatic Cancer
Charles C. Hsu et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2012)
A phase II study of oral S-1 with concurrent radiotherapy followed by chemotherapy with S-1 alone for locally advanced pancreatic cancer
Hiroyuki Shinchi et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2012)
Pancreatic Adenocarcinoma, Version 2.2012 Featured Updates to the NCCN Guidelines
Margaret A. Tempero et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2012)
Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer
De-shen Wang et al.
MEDICAL ONCOLOGY (2012)
An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study
M. J. Proctor et al.
BRITISH JOURNAL OF CANCER (2011)
PHASE II STUDY OF ORAL S-1 AND CONCURRENT RADIOTHERAPY IN PATIENTS WITH UNRESECTABLE LOCALLY ADVANCED PANCREATIC CANCER
Kentaro Sudo et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
NeoGemOx: Gemcitabine and oxaliplatin as neoadjuvant treatment for locally advanced, nonmetastasized pancreatic cancer
Klaus Sahora et al.
SURGERY (2011)
Preoperative Neutrophil-to-Lymphocyte Ratio (NLR) is Associated with Reduced Disease-free Survival Following Curative Resection of Pancreatic Adenocarcinoma
G. Garcea et al.
WORLD JOURNAL OF SURGERY (2011)
Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio
Imran Bhatti et al.
AMERICAN JOURNAL OF SURGERY (2010)
Serum CA19-9 Alterations During Preoperative Gemcitabine-Based Chemoradiation Therapy for Resectable Invasive Ductal Carcinoma of the Pancreas as an Indicator for Therapeutic Selection and Survival
Hidenori Takahashi et al.
ANNALS OF SURGERY (2010)
The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer
G. Kasymjanova et al.
Current Oncology (2010)
Role of systemic inflammatory response in predicting survival in patients with primary operable cancer
Campbell S. D. Roxburgh et al.
FUTURE ONCOLOGY (2010)
Phase II Study of Gemcitabine Chemotherapy Alone for Locally Advanced Pancreatic Carcinoma: JCOG0506
Hiroshi Ishii et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2010)
Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma
Richard A. Smith et al.
AMERICAN JOURNAL OF SURGERY (2009)
Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement
Mark P. Callery et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head
Douglas B. Evans et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Borderline resectable pancreatic cancer: The importance of this emerging stage of disease
Matthew H. G. Katz et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2008)
An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer
Donald C. McMillan
PROCEEDINGS OF THE NUTRITION SOCIETY (2008)
Surrogate markers of resectability in patients undergoing exploration of potentially resectable pancreatic adenocarcinoma
S. L. Ong et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2008)
Delayed gastric emptying (DGE) after pancreatic surgery:: A suggested definition by the International Study Group of Pancreatic Surgery (ISGPS)
Moritz N. Wente et al.
SURGERY (2007)
Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma
Chandrajit P. Raut et al.
ANNALS OF SURGERY (2007)
Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic body cancer - Long-term results
Satoshi Hirano et al.
ANNALS OF SURGERY (2007)
Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer
Timothy M. Pawlik et al.
SURGERY (2007)
Borderline resectable pancreatic cancer: Definitions, management, and role of preoperative therapy
Gauri R. Varadhachary et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer
SR Walsh et al.
JOURNAL OF SURGICAL ONCOLOGY (2005)
Prognostic factors in advanced cancer patients:: Evidence-based clinical recommendations -: A study by the Steering Committee of the European Association for Palliative Care
M Maltoni et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Postoperative pancreatic fistula: An international study group (ISGPF) definition
C Bassi et al.
SURGERY (2005)
Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trial
C Bassi et al.
DIGESTIVE SURGERY (2005)
Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey
D Dindo et al.
ANNALS OF SURGERY (2004)
Correlation of pre-operative nutritional condition with post-operative complications in surgical treatment for oesophageal carcinoma
T Nozoe et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2002)
Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial
JP Neoptolemos et al.
ANNALS OF SURGERY (2001)
Share Paper
